Targeting the gut–joint axis: an oral Spirulina hydrogel as an adjuvant strategy for rheumatoid arthritis therapy
Trends in Biotechnology · 2026
DOI: 10.1016/j.tibtech.2026.02.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Biotechnology, 2026. Verfasst von Ruoxi Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Eye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310000, China; Institute of Translational Medicine, Zhej…. Hauptthemen laut MEDLINE: Spirulina, Arthritis, Rheumatoid, Hydrogels. Die Arbeit nennt 59 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, National Key Research and Development Program of China, National Key Research and Development Program of China Stem Cell and Translational Research.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is linked to gut barrier dysfunction and microbiota dysbiosis. We developed an oral Spirulina platensis-based hydrogel (SP-gel) with favorable physicochemical properties (gastric retention-intestinal sustained release). In vitro, SP-gel restored intestinal barrier integrity and alleviated inflammation. In vivo, oral SP-gel (especially combined with intra-articular hyaluronic acid) ameliorated joint inflammation, bone erosion, and cartilage degradation in collagen-induced arthritis mice. Mechanistically, SP-gel reinforced the gut barrier, rebalanced immunity (regulatory T/t helper 17 cells) and remodeled gut microbiota. It also showed good biosafety and enhanced methotrexate efficacy. Our findings highlight SP-gel's potential as a safe oral adjuvant therapy for RA targeting the gut-joint axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310000, China; Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, China; Zhejiang University-Ordos Cit…
- Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University School of Medicine, Zhejiang University, Haining 314400, China; Zhejiang University-Ordos City Etuoke Banner Joint Research…
- Eye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310000, China; Liangzhu Laboratory, Zhejiang University, School of Medicine, Zhejiang University, Hangzhou 310009, China; Zhej…
- Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, China; Zhejiang University-Ordos City Etuoke Banner Joint Research Center, Zhejiang University, Haining 314400, China.
- Eye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310000, China; Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University School of Medici…
- Clinical Medical College & Affiliated Hospital, Chengdu University, Chengdu 610081, China. Electronic address: yangjin@cdu.edu.cn.
Förderung
- Natural Science Foundation of Shandong Province
- National Key Research and Development Program of China
- National Key Research and Development Program of China Stem Cell and Translational Research
- Primary Research and Development Plan of Zhejiang Province
Zitieren
APA
Wang, R., Tong, A., Zhu, H., Lin, D., Cui, J., Liu, X., Dong, J., Yang, J., & Zhou, M. (2026). Targeting the gut–joint axis: an oral Spirulina hydrogel as an adjuvant strategy for rheumatoid arthritis therapy. Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2026.02.004
Vancouver
Wang R, Tong A, Zhu H, Lin D, Cui J, Liu X, et al. Targeting the gut–joint axis: an oral Spirulina hydrogel as an adjuvant strategy for rheumatoid arthritis therapy. Trends in Biotechnology. 2026. doi:10.1016/j.tibtech.2026.02.004
BibTeX
@article{Wang2026,
author = {Wang, Ruoxi and Tong, Aiying and Zhu, Haishuang and Lin, Donghu and Cui, Jiarong and Liu, Xiaoyang and Dong, Jia and Yang, Jin and Zhou, Min},
title = {Targeting the gut–joint axis: an oral Spirulina hydrogel as an adjuvant strategy for rheumatoid arthritis therapy},
journal = {Trends in Biotechnology},
year = {2026},
doi = {10.1016/j.tibtech.2026.02.004}
}
EUVIMED